1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
(
- Contribution to journal › Article
- 2022
-
Mark
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex
(
- Contribution to journal › Article
-
Mark
Rutinmässig screening med APTT är inte indicerad före operation
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
(
- Contribution to journal › Article
- 2017
-
Mark
Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments
(
- Contribution to journal › Article
- 2016
-
Mark
Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits : A two-center study
(
- Contribution to journal › Article
-
Mark
Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact : A case report
(
- Contribution to journal › Article
- 2015
-
Mark
Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
(
- Contribution to journal › Article
-
Mark
One-stage vs. chromogenic assays in haemophilia A
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Laboratory aspects of von Willebrand disease : test repertoire and options for activity assays and genetic analysis
(
- Contribution to journal › Scientific review